DoctorsJesse L. Berry, MD

Jesse L. Berry, MD

Title: Associate Professor of Ophthalmology (Clinical Scholar), Associate Director of Ocular Oncology at Children's Hospital Los Angeles (CHLA) and USC Roski Eye Institute

Department: Ophthalmology

Clinical Specialty: Ocular Oncology and Pediatric Ophthalmology

Treatment Expertise: Ocular Oncology, Melanoma, Retinoblastoma

Certification: American Board of Ophthalmology

Languages: English, Spanish

Location: Los Angeles and Children’s Hospital Los Angeles

Research Topics:

Choroidal Melanoma
Ocular Oncology
Clinical Outcomes

Biography and Education


Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center. She then completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles under the mentorship of Drs. Jonathan Kim and A. Linn Murphree. Dr. Berry is the founder of WOO, Women in Ocular Oncology.

Dr. Jesse Berry has served as a medical expert on the following USCREI posts:

Research Interests:

Evaluation of the aqueous humor for tumor-derived genetic information and its application to prognosis and precision medicine for retinoblastoma patients. Investigating new methods of chemotherapy delivery for the treatment of Retinoblastoma. Evaluating treatment outcomes for Retinoblastoma eyes. This includes evaluation of treatment outcomes after systemic chemotherapy and the elucidation of factors present at diagnosis, which contribute to final visual outcome in eyes treated for retinoblastoma.

Watch Dr. Berry discuss her latest research at the AAO 2017 Conference in New Orleans, Louisiana!


  • BA, Harvard College, Biochemical Sciences, 2004
  • MD, Harvard Medical School, Medicine, 2008


  • Memorial Sloan Kettering Cancer Center, 2008-2009


  • LAC+USC, Ophthalmology, 2009-2012


  • CHLA, USC, Ocular Oncology, 2013-2014


Professional society memberships:

  • American Academy of Ophthalmology, 2009-present
  • Association for Research in Vision & Ophthalmology, 2009-present
  • International Society of Ocular Oncology, 2008-present
  • American Society of Cataract and Refractive Surgery, 2012-present
  • Women in Ophthalmology, 2012-present
  • California Association of Eye Physicians and Surgeons, 2011-present
  • Los Angeles Society of Ophthalmology, 2011-present
  • Society of Heed Fellows, 2013-present


  • Harvard College Scholarship: Elizabeth Cary Agassiz Scholar, 2000-2004
  • Malcolm Kinsberg Scholarship, 2000-2004
  • Kappa Alpha Theta Foundation Scholarship, 2002
  • David Rockefeller Center of Latin American Studies Grant, 2003
  • Nevil & Louise Ford Scholarship Fund, 2004-2008
  • Harvard Medical International Initiatives in Research Grant, 2005
  • Center for Eye Research and Education McCleary Grant, 2007
  • Department of Ophthalmology, USC, Medical Knowledge Award, 2011
  • Starr Schulman Fellowship, 2012
  • Department of Health Services Innovation Grant, 2012
  • Heed Ophthalmic Foundation Fellow, 2013-2014
  • Society of Heed Fellows, 2013
  • University of Southern California Excellence in Resident Teaching Award, 2013
  • University of Southern California Excellence in Resident Teaching Award, 2014


  1. Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review. Brachytherapy. 2018 Nov – Dec;17(6):981-989.
  2. Berry JL, Xu L, Kooi I, Murphree AL, Prabakar RK, Reid M, Stachelek K, Le BHA, Welter L, Reiser BJ, Chevez-Barrios P, Jubran R, Lee TC, Kim JW, Kuhn P, Cobrinik D, Hicks J. Genomic cfdna analysis of aqueous humor in retinoblastoma predicts eye salvage: The surrogate tumor biopsy for retinoblastoma. Mol Cancer Res. 2018 Nov;16(11):1701-1712.
  3. Bellerive C, Berry JL, Polski A, Singh AD. Conjunctival squamous neoplasia: Staging and initial treatment. Cornea. 2018 Oct;37(10):1287-1291.
  4. Kogachi K, Kim JW, Green S, Jubran R, Berry JL. Lurking below: Massive choroidal invasion under a calcified tumor after attempted conservative therapy for retinoblastoma. Ophthalmic Genet. 2018 Oct;39(5):653-657.
  5. Lu JE, Francis JH, Dunkel IJ, Shields CL, Yu MD, Berry JL, Kogachi K, Skalet AH, Miller AK, Santapuram PR, Daniels AB, Abramson DH. Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017. Br J Ophthalmol. 2018 Oct 25
  6. Zolfaghari E, Kim JW, Krishnan S, Chevez-Barrios P, Berry JL. Atypical retinal pigment epithelial hyperplasia and glial proliferation masquerading as progressive recurrent retinoblastoma: A case report review and clinicopathologic correlation. Ocul Oncol Pathol. 2018 Sep;4(2):116-121.
  7. Polski A, Sibug Saber M, Kim JW, Berry JL. Extending far and wide: The role of biopsy and staging in the management of ocular surface squamous neoplasia. Clin Exp Ophthalmol. 2018 Aug 29
  8. Berry JL, Lewis L, Zolfaghari E, Green S, Le BHA, Lee TC, Murphree AL, Kim JW, Jubran R. Lack of correlation between age at diagnosis and rb1 mutations for unilateral retinoblastoma: The importance of genetic testing. Ophthalmic Genet. 2018 Jun;39(3):407-409.
  9. Berry JL, Cobrinik D, Hicks J. Potential of aqueous humor as a surrogate tumor biopsy for retinoblastoma-reply. JAMA Ophthalmol. 2018 May 1;136(5):598.
  10. Berry JL, Kogachi K, Jubran R, Kim JW. Loss of fundus view as an indication for secondary enucleation in retinoblastoma. Pediatr Blood Cancer. 2018 Apr;65(4).
  11. Shah S, Koban Y, Le BHA, Bechtold M, Zolfaghari E, Kim JW, Berry JL. Iris hypoplasia as the presenting sign of retinoblastoma in a child with a 13q deletion. J Pediatr Ophthalmol Strabismus. 2018 Apr 23;55:e10-e13.
  12. Kim JW, Jacobsen BH, Ko M, Lee DK, Jubran RF, Berry JL. Three Presentations of Cns Disease in Patients with Intraocular Retinoblastoma at a Tertiary Medical Center in the United States. Ophthalmic Genet. 2018 Jan-Feb;39(1):115-9.
  13. Lang P, Kim JW, McGovern K, Reid MW, Subramanian K, Murphree AL, Berry JL. Porous Orbital Implant after Enucleation in Retinoblastoma Patients: Indications and Complications. Orbit. 2018 Feb 20:1-6.
  14. Aziz HA, Kim JW, Munier FL, Berry JL. Acute Hemorrhagic Retinopathy Following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocul Oncol Pathol. 2017 Jan;3(1):34-40.
  15. Berry JL, Anulao K, Kim JW. Optical Coherence Tomography Imaging of a Large Spherical Seed in Retinoblastoma. Ophthalmology. 2017 Aug;124(8):1208.
  16. Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 2017 Dec;124(12):1817-25.
  17. Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. Risk of Metastasis and Orbital Recurrence in Advanced Retinoblastoma Eyes Treated with Systemic Chemoreduction Versus Primary Enucleation. Pediatr Blood Cancer. 2017 Apr;64(4).
  18. Berry JL, Kogachi K, Jubran R, Kim JW. Loss of Fundus View as an Indication for Secondary Enucleation in Retinoblastoma. Pediatr Blood Cancer. 2017 Dec. [Epub ahead of print]
  19. Berry JL, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW. Long-Term Outcomes of Group D Retinoblastoma Eyes During the Intravitreal Melphalan Era. Pediatr Blood Cancer. 2017 Dec;64(12).
  20. Berry JL, Xu L, Murphree AL, Krishnan S, Stachelek K, Zolfaghari E, McGovern K, Lee TC, Carlsson A, Kuhn P, Kim JW, Cobrinik D, Hicks J. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma. JAMA Ophthalmol. 2017 Nov;135(11):1221-30.
  21. Francis JH, Abramson DH, Ji X, Shields CL, Teixeira LF, Schefler AC, Cassoux N, Hadjistilianou D, Berry JL, Frenkel S, Munier FL. Risk of Extraocular Extension in Eyes with Retinoblastoma Receiving Intravitreous Chemotherapy. JAMA Ophthalmol. 2017 Nov. [Epub ahead of print]
  22. Kim JW, Jacobsen B, Zolfaghari E, Ferrario A, Chevez-Barrios P, Berry JL, Lee DK, Rico G, Madi I, Rao N, Stachelek K, Wang LC, Gomer C. Rabbit Model of Ocular Indirect Photodynamic Therapy Using a Retinoblastoma Xenograft. Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2363-73.
  23. Kim JW, Jacobsen BH, Ko M, Lee DK, Jubran RF, Berry JL. Three Presentations of Cns Disease in Patients with Intraocular Retinoblastoma at a Tertiary Medical Center in the United States. Ophthalmic Genet. 2017 Sep:1-5. [Epub ahead of print]
  24. Scelfo C, Francis JH, Khetan V, Jenkins T, Marr B, Abramson DH, Shields CL, Pe’er J, Munier F, Berry J, Harbour JW, Yarovoy A, Lucena E, Murray TG, Bhagia P, Paysse E, Tuncer S, Chantada GL, Moll AC, Ushakova T, Plager DA, Ziyovuddin I, Leal CA, Materin MA, Ji XD, Cursino JW, Polania R, Kiratli H, All-Ericsson C, Kebudi R, Honavar SG, Vishnevskia-Dai V, Epelman S, Daniels AB, Ling JD, Traore F, Ramirez-Ortiz MA. An International Survey of Classification and Treatment Choices for Group D Retinoblastoma. Int J Ophthalmol. 2017 Jun;10(6):961-7.
  25. Wong BJ, Berry JL. Acute Lymphoblastic Leukemia Relapse Presenting as Optic Nerve Infiltration. JAMA Ophthalmol. 2017 Jan;135(1):e164656.
  26. Berry JL, Cobrinik D, Kim JW. Detection and Intraretinal Localization of an ‘Invisible’ Retinoblastoma Using Optical Coherence Tomography. Ocul Oncol Pathol. 2016 Apr;2(3):148-52.
  27. Berry JL, Shih G, Moysidis SN, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Patterns of Subretinal Fluid Resolution in Group D Eyes Treated with Chemoreduction: Experience from the Children’s Hospital Los Angeles/University of Southern California. Ophthalmic Genet. 2016 Mar 2:1-4.
  28. Marvasti AH, Berry J, Sibug ME, Kim JW, Huang AS. Anterior Segment Scleral Fluorescein Angiography in the Evaluation of Ciliary Body Neoplasm: Two Case Reports. Case Rep Ophthalmol. 2016 Jan-Apr;7(1):30-8.
  29. Jacobsen BH, Berry JL, Jubran R, Kim JW. Orbital Recurrence Following Aggressive Laser Treatment for Recurrent Retinoblastoma. Ocul Oncol Pathol. 2015 Dec;2(2):76-9.
  30. Zhu D, Berry JL, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children’s Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec;2(2):105-11.
  31. Browne AW, Dandapani SV, Jennelle R, Stevanovic M, Lee TC, Murphree AL, et al. Outcomes of Medium Choroidal Melanomas Treated with Ruthenium Brachytherapy Guided by Three-Dimensional Pretreatment Modeling. Brachytherapy. 2015;14(5):718-25. Epub 2015/06/16. doi: 10.1016/j.brachy.2015.04.010. PubMed PMID: 26073224.
  32. Berry JL, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocular Oncology and Pathology. 2015;1(2):103-10.
  33. Liu W, Rootman DB, Berry JL, Hwang CJ, Goldberg RA. Methicillin-Resistant Staphylococcus Aureus Dacryoadenitis. JAMA Ophthalmology. 2014;132(8):993-5. Epub 2014/05/31. doi: 10.1001/jamaophthalmol.2014.965. PubMed PMID: 24875129.
  34. Berry JL, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Factors Predictive of Long-Term Visual Outcomes of Group D Eyes Treated with Chemoreduction and Low-Dose IMRT Salvage: The Children’s Hospital Los Angeles Experience. The British Journal of Ophthalmology. 2014;98(8):1061-5. Epub 2014/03/29. doi: 10.1136/bjophthalmol-2013-304411. PubMed PMID: 24671926.
  35. Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, et al. Long-Term Outcomes of Group D Eyes in Bilateral Retinoblastoma Patients Treated with Chemoreduction and Low-Dose IMRT Salvage. Pediatric Blood & Cancer. 2013;60(4):688-93. Epub 2012/09/22. doi: 10.1002/pbc.24303. PubMed PMID: 22997170.
  36. Berry JL, Dandapani SV, Stevanovic M, Lee TC, Astrahan M, Murphree AL, et al. Outcomes of Choroidal Melanomas Treated with Eye Physics: A 20-year Review. JAMA Ophthalmology. 2013;131(11):1435-42. Epub 2013/09/07. doi: 10.1001/jamaophthalmol.2013.4422. PubMed PMID: 24008431.
  37. Berry JL, Cuzzo LM, Bababeygy SR, Quiros PA. Unmet Need for Corrective Eyeglasses: Results from a Los Angeles County Hospital Survey. International Ophthalmology. 2012;32(3):245-50. Epub 2012/04/11. doi: 10.1007/s10792-012-9561-1. PubMed PMID: 22487855.
  38. Lee NG, Berry JL, Lee TC, Wang AT, Honowitz S, Murphree AL, et al. Sonoporation Enhances Chemotherapeutic Efficacy in Retinoblastoma Cells in vitro. Investigative Ophthalmology & Visual Science. 2011;52(6):3868-73. Epub 2011/01/29. doi: 10.1167/iovs.10-6501. PubMed PMID: 21273549; PubMed Central PMCID: PMCPmc3109062.
  39. Graeber CP, Gobin YP, Marr BP, Dunkel IJ, Brodie SE, Bornfeld N, et al. Histopathologic Findings of Eyes Enucleated after Treatment with Chemosurgery for Retinoblastoma. The Open Ophthalmology Journal. 2011;5:1-5. Epub 2011/03/15. doi: 10.2174/1874364101105010001. PubMed PMID: 21399766; PubMed Central PMCID: PMCPmc3052645.
  40. Brauner SC, Berry JL, Pye J, Lee EG, Rhee DJ. Effect of Saline Conditions on the Tensile Strength of Ophthalmic Sutures. Ophthalmic Surgery, Lasers & Imaging : The Official Journal of the International Society for Imaging in the Eye. 2011;42(2):148-51. Epub 2010/12/02. doi: 10.3928/15428877-20101124-01. PubMed PMID: 21117584.
  41. Maki JL, Marr BP, Abramson DH. Diagnosis of Retinoblastoma: How Good are Referring Physicians? Ophthalmic Genetics. 2009;30(4):199-205. Epub 2009/10/27. doi: 10.3109/13816810903258837. PubMed PMID: 19852578.
  42. Maki J, Qualls M, White B, Kleefield S, Crone R. Health Impact Assessment and Short-Term Medical Missions: A Methods Study to Evaluate Quality of Care. BMC Health Services Research. 2008;8:121. Epub 2008/06/04. doi: 10.1186/1472-6963-8-121. PubMed PMID: 18518997; PubMed Central PMCID: PMCPmc2464597.
  43. Maki J, Kusakul S, Morley K, Sanguansak T, Seddon J, Hartung L, et al. The Effect of Glasses on Visual Function Following Cataract Surgery in a Cataract Camp. The British Journal of Ophthalmology. 2008;92(7):883-7. Epub 2008/06/26. doi: 10.1136/bjo.2007.132423. PubMed PMID: 18577636.
  44. Maki JL, Nesti HA, Shetty RK, Rhee DJ. Transcorneal Tube Extrusion in a Child with a Baerveldt Glaucoma Drainage Device. Journal of AAPOS : The Official Publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus. 2007;11(4):395-7. Epub 2007/04/06. doi: 10.1016/j.jaapos.2006.12.057. PubMed PMID: 17409000.